In this episode, we explore the evolution and future of the Pharmacy Benefit Management (PBM) industry with insights from two seasoned pharma managed care executives. We discuss the early role of PBMs, their acquisition by pharmaceutical companies, and subsequent industry consolidation. We examine how vertical integration of the PBMs transformed their business model, including the restricted formularies that gave rise to rebates. We also address evolving PBM-manufacturer relationships, the effects of public scrutiny, and predictions for key trends. Join us for a comprehensive look at the past, present, and future of PBMs, focusing on the changes needed to better serve patients.
Steve Stefano, Managing Director, ReprizioRx
Steve.Stefano@repriziorx.com
Bill Leonard, Managing Director, ReprizioRX
wjl@repriziorx.com
ReprizioRX
PBMs
IPA model HMO
Medco
Metro Containment Services
Medicare Catastrophic Coverage Act of 1988
Merck
SmithKline Beecham
Eli Lilly
340B
NDC blocks
Group Purchasing Organizations (GPOs)
Medicare
United Healthcare
FTC
CostPlusDrugs
Questions or comments?
Email us at comments@prescriptionforbetteraccess.com.
Find us on social media! Follow us on X, LinkedIn, YouTube and Threads.
